Ciprofloxacin + Dexamethasone is an ophthalmic (eye-drop) medication that combines two active ingredients: ciprofloxacin, a broad-spectrum fluoroquinolone antibiotic, and dexamethasone, a potent corticosteroid. The solution is formulated as a sterile eye drop at a concentration of 0.3 % ciprofloxacin and 0.1 % dexamethasone. In Hong Kong, the product is classified as a prescription-only medicine and is regulated by the Hong Kong Department of Health (DH).
The combination is intended to treat bacterial eye infections while simultaneously reducing ocular inflammation. The antibiotic component tackles the infectious organisms, and the steroid component moderates swelling, redness, and discomfort.
Ciprofloxacin belongs to the fluoroquinolone class. It inhibits bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA replication and transcription. By blocking these enzymes, ciprofloxacin prevents bacterial cells from multiplying, leading to their elimination. The drug is active against a wide range of Gram-positive and Gram-negative ocular pathogens, including Staphylococcus aureus, Streptococcus pneumoniae, and Pseudomonas aeruginosa.
Dexamethasone is a synthetic glucocorticoid. It binds to intracellular glucocorticoid receptors, altering gene transcription and suppressing the production of inflammatory mediators such as prostaglandins, leukotrienes, and cytokines. This reduces vascular permeability, edema, and the infiltration of inflammatory cells into the eye, alleviating redness, pain, and photophobia.
When used together, the antibiotic rapidly curtails bacterial growth while the steroid quickly dampens the inflammatory response that often accompanies infection. This dual action can improve patient comfort and potentially speed visual recovery, provided the medication is used under appropriate medical supervision.
In Hong Kong, the product is approved for the following ophthalmic indications:
These indications are based on the product’s ability to address both infection and inflammation in the same formulation, reducing the need for separate antibiotic and steroid eye drops.
Current peer-reviewed literature does not provide robust evidence for routine off-label use of Ciprofloxacin + Dexamethasone in conditions such as viral conjunctivitis, allergic keratoconjunctivitis, or non-infectious uveitis. Whenever off-label application is contemplated, it requires careful risk-benefit assessment by an ophthalmologist and must comply with local regulatory guidance.
If any of these conditions apply, clinicians should evaluate alternative therapies.
If you take other ophthalmic medications, inform your ophthalmologist before starting Ciprofloxacin + Dexamethasone.
This article provides educational information about Ciprofloxacin + Dexamethasone and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
It is generally advisable to remove contact lenses before instilling the drops and wait at least 15 minutes before reinserting them. This prevents drug dilution and reduces the risk of lens-related irritation.
Patients often notice a reduction in redness and discomfort within a few hours, but the antibiotic effect may require 24-48 hours to significantly decrease bacterial load.
If you have pre-existing glaucoma, the steroid component can increase intra-ocular pressure. Close monitoring by an eye specialist is essential, and alternative therapies may be preferred.
Swallowing a small amount is unlikely to cause serious harm, but you may experience mild gastrointestinal upset. Contact your healthcare provider if you notice persistent nausea or abdominal discomfort.
No. Steroids can worsen viral infections such as herpes simplex keratitis, and the antibiotic component offers no benefit against viruses. Separate antiviral therapy is required.
Yes. The bottle should be stored in a dark place or a closed container to maintain stability, as both ciprofloxacin and dexamethasone can degrade when exposed to light.
Improper or prolonged use of fluoroquinolone eye drops can contribute to bacterial resistance. Use the medication exactly as prescribed and complete the full course.
You can use other ophthalmic preparations, but they should be spaced at least 5 minutes apart to avoid dilution. Consult your ophthalmologist before combining treatments.
Ciprofloxacin + Dexamethasone is a prescription-only ophthalmic medicine approved by the Hong Kong Department of Health. It must be dispensed by a licensed pharmacist following a doctor’s order.
